Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-047197

See Remarks sold 150,000 shares at $2.80 ($420,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KINGSLEY ALFRED D See Remarks 2017-07-31 Sale −150,000 $2.80 $420,000 5,781,555 D
Open-market sales · 150,000 sh · avg $2.80 · $420,000
Loading xslF345X03/doc4.xml…